Business Context and Reporting Period
This Form 8-K was filed by 8i Acquisition 2 Corp., a special purpose acquisition company, on December 13, 2021, with the report signed December 14, 2021. The provided filing does not identify EUDA Health Holdings Ltd. as the registrant.
Material Event
Under Item 8.01, the company announced that holders of its units could elect to separately trade the ordinary shares, redeemable warrants, and rights beginning on or about December 14, 2021.
- Units not separated continued trading under Nasdaq symbol LAXXU.
- Ordinary shares traded under LAX.
- Redeemable warrants traded under LAXXW.
- Rights traded under LAXXR.
The securities were listed on the Nasdaq Global Market. The filing includes the related December 13, 2021 press release as Exhibit 99.1.
Financial Metrics and Liquidity
The filing does not provide revenue, profit, cash flow, margins, debt, liquidity, operating results, or other financial metrics.
Guidance, Risks, and Unusual Items
The filing provides no financial guidance, operating outlook, management commentary, risk updates, contingencies, or unusual accounting items. The reported event concerns only the separation and trading of securities included in the company’s units.
Investor Verification Items
- Verify the registrant and filing linkage, because the supplied metadata names EUDA Health Holdings Ltd., while the filing names 8i Acquisition 2 Corp.
- Confirm the effective trading date and current Nasdaq status of LAX, LAXXW, LAXXR, and LAXXU.
- Review Exhibit 99.1 for additional terms or disclosures regarding the unit separation.
- Confirm the terms of the warrants and rights before evaluating potential dilution.